ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 62 filers reported holding ACUMEN PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,968,061 | +31.9% | 14,932,063 | +52.8% | 1.22% | +37.5% |
| Q2 2023 | $46,997,418 | +18.5% | 9,770,773 | 0.0% | 0.89% | -1.2% |
| Q1 2023 | $39,669,338 | -24.8% | 9,770,773 | 0.0% | 0.90% | -16.1% |
| Q4 2022 | $52,762,174 | -46.2% | 9,770,773 | 0.0% | 1.07% | -48.8% |
| Q3 2022 | $98,001,000 | +113.4% | 9,770,773 | 0.0% | 2.09% | +70.8% |
| Q2 2022 | $45,923,000 | +20.2% | 9,770,773 | 0.0% | 1.22% | +46.8% |
| Q1 2022 | $38,204,000 | -42.2% | 9,770,773 | 0.0% | 0.83% | -28.4% |
| Q4 2021 | $66,050,000 | -54.5% | 9,770,773 | 0.0% | 1.16% | -42.1% |
| Q3 2021 | $145,194,000 | – | 9,770,773 | – | 2.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $18,452 | 5.05% |
| Knollwood Investment Advisory, LLC | 1,678,510 | $9,063,954 | 3.55% |
| GUARDIAN POINT CAPITAL, LP | 300,000 | $1,620,000 | 1.28% |
| GREAT POINT PARTNERS LLC | 1,116,581 | $6,029,537 | 1.18% |
| RA Capital Management | 9,770,773 | $52,762,174 | 1.07% |
| Deep Track Capital, LP | 3,952,000 | $21,340,800 | 0.90% |
| Cheyne Capital Management (UK) LLP | 55,829 | $301,477 | 0.53% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 295,115 | $1,593,621 | 0.46% |
| COMMODORE CAPITAL LP | 498,315 | $2,691 | 0.41% |
| Ikarian Capital, LLC | 254,945 | $1,376,703 | 0.33% |